HIV-1 Genotyping Kit with Integrase

The kit enables reliable genotyping of HIV-1 from human EDTA plasma and dried blood spot (DBS) samples to detect resistance to protease, nucleoside reverse-transcriptase, non-nucleoside reverse- transcriptase, and integrase inhibitors. The World Health Organization (WHO) recommends that HIV drug resistance prevention, monitoring, and response be integrated into every national HIV program and into routine cascade data review activities. With the adoption of integrase inhibitor treatment, monitoring of drug resistance is critical to establish a baseline and to proactively prevent unnecessary emergence and transmission of HIV